There are six anti-apoptotic Bcl-2 family members identified and several of these appear to contribute to drug resistance in cancer cells [37,38], suggesting that inhibition of multiple Bcl-2 family members will be necessary to achieve an optimal therapeutic effect. The gene discussed is BCL2; the disease is cancer.